Navigation Links
Putting a new spin on current research
Date:11/14/2008

Physicists in the USA and at the London Centre for Nanotechnology have found a way to extend the quantum lifetime of electrons by more than 5,000 per cent, as reported in this week's Physical Review Letters. Electrons exhibit a property called 'spin' and work like tiny magnets which can point up, down or a quantum superposition of both. The state of the spin can be used to store information and so by extending their life the research provides a significant step towards building a usable quantum computer.

"Silicon has dominated the computing industry for decades," says Dr Gavin Morley, lead author of the paper. "The most sensitive way to see the quantum behaviour of electrons held in silicon chips uses electrical currents. Unfortunately, the problem has always been that these currents damage the quantum features under study, degrading their usefulness."

Marshall Stoneham, Professor of Physics at UCL (University College London), commented: "Getting the answer from a quantum computation isn't easy. This new work takes us closer to solving the problem by showing how we might read out the state of electron spins in a silicon-based quantum computer."

To achieve the record quantum lifetime the team used a magnetic field twenty-five times stronger than those used in previous experiments. This powerful field also provided an additional advantage in the quest for practical quantum computing: it put the electron spins into a convenient starting state by aligning them all in one direction.


'/>"/>

Contact: Dave Weston
d.weston@ucl.ac.uk
44-020-767-97678
University College London
Source:Eurekalert  

Page: 1

Related biology technology :

1. Putting stem cell research on the fast track
2. New small-scale generator produces alternating current by stretching zinc oxide wires
3. Solos Endoscopy, Inc. in Final Stages to Upgrade Pink Sheet Status from Limited to Current Information
4. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on Current Business and COS Certification
5. 72% of Women Are Dissatisfied With Their Current Treatment of Vaginal Infection, Survey Finds
6. Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer
7. Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity
8. National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000
9. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
10. First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs
11. 800-Year-Old Mummies Aid Current Cold Cases:
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Putting a new spin on current research
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ("OncoSec") ... will host a Key Opinion Leader event to highlight ... oral and poster presentation at the upcoming 2017 ASCO-SITC ... KOL event will be held in-person and via live ... / 9:00 AM PST at the Lotte New York ...
(Date:2/23/2017)... TORONTO , Feb. 23, 2017 /PRNewswire/ - The ... Institute for Cancer Research (OICR) are pleased to report ... Series A financing, with Johnson & Johnson Innovation – ... investors include venture groups HealthCap, TPG Biotechnology Partners, and ... ...
(Date:2/23/2017)... Minn. , Feb. 23, 2017  Imanis ... new product line of oncolytic vaccinia viruses for ... Corporation as part of Genelux,s proprietary, vaccinia virus-based ... are excited to enter into a partnership with ... selected oncolytic vaccinia viruses for use in research," ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can ... adiponectin, uric acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect ... SalivaLab , the relationship between insulin and other relevant biomarkers can be extensively ...
Breaking Biology Technology:
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
Breaking Biology News(10 mins):